Kevin Talbot

Active 1995–2025

151
Papers
20,498
Citations
87
h-index
138
i10-index

Citations

Citations per year for Kevin Talbot1951: 1 citations1963: 1 citations1972: 1 citations1977: 2 citations1995: 2 citations1996: 15 citations1997: 26 citations1998: 19 citations1999: 17 citations2000: 15 citations2001: 5 citations2002: 11 citations2003: 5 citations2004: 24 citations2005: 34 citations2006: 31 citations2007: 48 citations2008: 56 citations2009: 83 citations2010: 131 citations2011: 146 citations2012: 163 citations2013: 206 citations2014: 208 citations2015: 210 citations2016: 263 citations2017: 314 citations2018: 248 citations2019: 851 citations2020: 1,045 citations2021: 994 citations2022: 871 citations2023: 676 citations2024: 996 citations2025: 455 citations2026: 11 citations1952–1962: no citations, so these years are not shown1964–1971: no citations, so these years are not shown1973–1976: no citations, so these years are not shown1978–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,232 citing papers, 21.7% of this breakdownUnited Kingdom: 1,268 citing papers, 12.4% of this breakdownItaly: 733 citing papers, 7.1% of this breakdownGermany: 638 citing papers, 6.2% of this breakdownChina: 584 citing papers, 5.7% of this breakdownCanada: 434 citing papers, 4.2% of this breakdownAustralia: 430 citing papers, 4.2% of this breakdownFrance: 381 citing papers, 3.7% of this breakdownNetherlands: 381 citing papers, 3.7% of this breakdownSpain: 295 citing papers, 2.9% of this breakdownBelgium: 239 citing papers, 2.3% of this breakdownSweden: 233 citing papers, 2.3% of this breakdown
0%21.7%Other 23.6%

Fields

  • Medicine66%
  • Biochemistry, Genetics and Molecular Biology21.8%
  • Neuroscience9.4%
  • Immunology and Microbiology0.6%
  • Computer Science0.4%
  • Engineering0.3%
  • Other1.5%

Topics

  • Amyotrophic Lateral Sclerosis Research15.6%
  • Neurogenetic and Muscular Disorders Research10.3%
  • Parkinson's Disease Mechanisms and Treatments5.8%
  • Genetic Neurodegenerative Diseases4.1%
  • Alzheimer's disease research and treatments3.2%
  • RNA Research and Splicing3%
  • Other58%

Coauthors

All papers

Open in search
  1. A proposal for new diagnostic criteria for ALS

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Clinical Neurophysiology 2020 cited by 574

  2. Extracellular vesicles in neurodegenerative disease — pathogenesis to biomarkers

    Authors: , , , , , , , - Nature Reviews Neurology 2016 cited by 424

  3. Neurofilament light chain

    Authors: , , , , , , , , , , , , , , , , - Neurology 2015 cited by 551

  4. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Duyang Kim, Nadia Propp, Samantha Fennessey, Delphine Fagegaltier, Hemali Phatnani, Maria Secrier, Elizabeth Fisher, Björn Oskarsson, Marka van Blitterswijk, Rosa Rademakers, N. R. Graff-Radford, Bradley F. Boeve, David S. Knopman, Ronald C. Petersen, Keith A. Josephs, E. Aubrey Thompson, Towfique Raj, Michael E. Ward, Dennis W. Dickson, Tania F. Gendron, Pietro Fratta, Leonard Petrucelli - Journal of Clinical Investigation 2020 cited by 257

  5. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrea Calvo, Elisabet Englund, Giuseppe Borghero, Gianluca Floris, Anne M. Remes, Hannu Laaksovirta, Leo McCluskey, John Q. Trojanowski, Vivianna M. Van Deerlin, Gerard D. Schellenberg, Michael A. Nalls, Vivian E. Drory, Chin‐Song Lu, Tu‐Hsueh Yeh, Hiroyuki Ishiura, Yuji Takahashi, Shoji Tsuji, Isabelle Le Ber, Alexis Brice, Carsten Drepper, Nigel Williams, Janine Kirby, Pamela J. Shaw, John Hardy, Pentti J. Tienari, Peter Heutink, Huw R. Morris, Stuart Pickering‐Brown, Bryan J. Traynor - The Lancet Neurology 2012 cited by 1,226

  6. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philippe Corcia, Philippe Couratier, Markus Weber, Julian Großkreutz, Albert C. Ludolph, Susanne Petri, Mamede de Carvalho, Philip Van Damme, Kevin Talbot, Martin R. Turner, Pamela J. Shaw, Ammar Al‐Chalabi, Adriano Chiò, Orla Hardiman, Karel G.M. Moons, Jan H. Veldink, Leonard H. van den Berg - The Lancet Neurology 2018 cited by 517

  7. Improving clinical trial outcomes in amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , - Nature Reviews Neurology 2020 cited by 291

  8. Axonal TDP-43 condensates drive neuromuscular junction disruption through inhibition of local synthesis of nuclear encoded mitochondrial proteins

    Authors: , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 139

  9. ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons

    Authors: , , , , , , , , , , , , , , , , , , , - Stem Cell Reports 2016 cited by 365

  10. Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Brain Communications 2022 cited by 81

  11. Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers

    Authors: , , , , , , , - Nature Reviews Neurology 2021 cited by 147

  12. Impairment of Mitochondrial Calcium Buffering Links Mutations in C9ORF72 and TARDBP in iPS-Derived Motor Neurons from Patients with ALS/FTD

    Authors: , , , , , , , , , - Stem Cell Reports 2020 cited by 131

  13. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frank Baas, Anneke J. van der Kooi, Marianne de Visser, Anneloor L.M.A. ten Asbroek, Peter C. Sapp, Diane McKenna‐Yasek, Meraida Polak, Seneshaw Asress, José Luís Muñoz-Blanco, Tim M. Strom, Thomas Meitinger, Karen Morrison, Giuseppe Lauria, Kelly L. Williams, P. Nigel Leigh, Garth A. Nicholson, Ian P. Blair, Claire S. Leblond, Patrick A. Dion, Guy A. Rouleau, Hardev Pall, Pamela J. Shaw, Martin R. Turner, Kevin Talbot, Franco Taroni, Khrista Boylan, Marka van Blitterswijk, Rosa Rademakers, Jesús Esteban‐Pérez, Alberto García‐Redondo, Phillip Van Damme, Wim Robberecht, Adriano Chiò, Cinzia Gellera, Carsten Drepper, Michael Sendtner, Antonia Ratti, Jonathan D. Glass, Jesús S. Mora, Nazlı Başak, Orla Hardiman, Albert C. Ludolph, Peter M. Andersen, Jochen H. Weishaupt, Robert H. Brown, Ammar Al‐Chalabi, Vincenzo Silani, Christopher E. Shaw, Leonard H. van den Berg, Jan H. Veldink, John E. Landers - Nature Genetics 2016 cited by 294

  14. C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9

    Authors: , , , , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 72

  15. Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alberto García‐Redondo, Jesús Esteban‐Pérez, Cinzia Tiloca, Federico Verde, Stefano Duga, Nigel Leigh, Hardev Pall, Karen Morrison, Ammar Al‐Chalabi, Pamela J. Shaw, Janine Kirby, Martin R. Turner, Kevin Talbot, Orla Hardiman, Jonathan D. Glass, Jacqueline de Belleroche, Masatoshi Maki, Stephen E. Moss, Christopher C.J. Miller, Cinzia Gellera, Antonia Ratti, Safa Al‐Sarraj, Robert H. Brown, Vincenzo Silani, John E. Landers, Christopher E. Shaw - Science Translational Medicine 2017 cited by 247

  16. The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort

    Authors: , , , , , , - Parkinsonism & Related Disorders 2013 cited by 302

  17. The clinical landscape for SMA in a new therapeutic era

    Authors: , - Gene Therapy 2017 cited by 174

  18. Exome-wide Rare Variant Analysis Identifies TUBA4A Mutations Associated with Familial ALS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , José Luís Muñoz-Blanco, Michael A. Simpson, Wouter van Rheenen, Frank P. Diekstra, Giuseppe Lauria, Stefano Duga, Stefania Corti, Cristina Cereda, Lucia Corrado, Gianni Sorarú, Karen Morrison, Kelly L. Williams, Garth A. Nicholson, Ian P. Blair, Patrick A. Dion, Claire S. Leblond, Guy A. Rouleau, Orla Hardiman, Jan H. Veldink, Leonard H. van den Berg, Ammar Al‐Chalabi, Hardev Pall, Pamela J. Shaw, Martin R. Turner, Kevin Talbot, Franco Taroni, Alberto García‐Redondo, Zheyang Wu, Jonathan D. Glass, Cinzia Gellera, Antonia Ratti, Robert H. Brown, Vincenzo Silani, Christopher E. Shaw, John E. Landers, Sandra D’Alfonso, Letizia Mazzini, Giacomo P. Comi, Roberto Del Bo, Mauro Ceroni, Stella Gagliardi, Giorgia Querin, Cinzia Bertolin - Neuron 2014 cited by 370

  19. C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

    Authors: , , , , , , , , , , , , , , - Stem Cells 2016 cited by 244

  20. Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair

    Authors: , , , , , , , , , , - Human Molecular Genetics 2020 cited by 76

  21. CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis

    Authors: , , , , , , , , , - Clinical Proteomics 2020 cited by 60

  22. Targeting phosphoglycerate kinase 1 with terazosin improves motor neuron phenotypes in multiple models of amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , - EBioMedicine 2022 cited by 56

  23. HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease

    Authors: , , , , , , , , , , , , , , - Brain 2017 cited by 122

  24. The impact of age on genetic testing decisions in amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jan H. Veldink, Patrick Vourc’h, Markus Weber, Ammar Al‐Chalabi - Brain 2022 cited by 48